May 20th 2022
Expert perspectives on treatment options for patients with uncommon EGFR mutations in non–small cell lung cancer.
March 17th 2021
Drs Toni Choueiri and Robert J. Motzer reflect on recent data supporting the use of TKI/I-O combination regimens for frontline treatment of metastatic renal cell carcinoma.